Company news

Arbutus Biopharma Corporation news in 2019

Arbutus Biopharma Corporation's news releases, calls and decks from 2019, newest first.

View company

Arbutus Reports Third Quarter 2019 Financial Results and Provides Corporate Update

November 5, 2019

Arbutus to Report Third Quarter 2019 Financial Results

October 29, 2019

Arbutus Announces Decision to Discontinue Development of AB-506, an Oral Capsid Inhibitor for the Treatment of Chronic Hepatitis B

October 2, 2019

Decks in 2019